Eli Lilly and CompanyPublication
Eli Lilly publishes application for KRAS G12C inhibitors.
The filing
Eli Lilly and Company published an application titled "KRAS G12C INHIBITORS" on November 12, 2026. The application is available at US20260356850A1 (opens in a new tab).
This filing’s full text wasn’t read for this issue, so its claims and the applicant’s background aren’t shown. Both are in the record, under Sources.